🇺🇸 FDA
Patent

US 8003693

Modulation of anxiety through blockade of anandamide hydrolysis

granted A61PA61P25/00A61P25/02

Quick answer

US patent 8003693 (Modulation of anxiety through blockade of anandamide hydrolysis) held by The Regents of the University of California expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61P, A61P25/00, A61P25/02, A61P25/04, A61P25/08